Using a luciferase reporter system, we found that the promoter constructs of USP22 displayed relatively higher activity in HeLa cells than in HFL1, cells indicating abnormal transcriptional activity of the USP22 gene in human tumor cells. This evidence concerns the gene CFHR1 and neoplasm.